The importance of serostatus awareness in arresting the spread of HIV

Mayer, Kenneth R.; Kippax, Susan; Sohn, Annette H.; Bras, Marlène

doi:10.1002/jia2.25217

Cited by 1 publication

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While the diagnostic value of screening may be lower in people who have never injected when compared to PWID, this is a critical population to keep engaged in prevention efforts, because of the risk of future transition to injection drug use. Routine screening, informing patients of their HCV status and normalizing conversations about HCV risk reduction may play an important part in prevention education—similar to approaches taken to prevent HIV 35,36 …”

Section: Discussionmentioning

confidence: 99%

Hepatitis C testing and treatment uptake among young people who use opioids in New York City: A cross‐sectional study

Kapadia

Katzman

Fong

et al. 2020

Journal of Viral Hepatitis

View full text Add to dashboard Cite

Fuelled by the opioid crisis, the incidence of hepatitis C virus (HCV) infection in people who use drugs is rising. 1 In national surveillance data, the highest incidence of acute HCV infection is in individuals aged 20-29. 2 This incidence is driven by initiation of injection drug use in this age group: 20% of individuals become HCV-infected within two years of starting to inject drugs, and half within five years. 3 People who use drugs but do not report a history of injection are also at higher risk for hepatitis C than the general population, possibly due to sexual risk or because of unreported injection drug use. 4,5 Several jurisdictions, including New York City, have seen a new peak of HCV prevalence in this younger age group. 6,7 If HCV elimination efforts are to be effective, engaging and treating

show abstract

Section: Discussionmentioning

confidence: 99%